SCHEMBL6352172

SCHEMBL6352172

CCCCN(CCCC)C(=O)c1ccc(B(O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.57
ERBB2 P04626 2/20 0.57
HPGD P15428 3/20 0.55
GAA P10253 1/20 0.55
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
LPL P06858 4/20 0.50
LIPG Q9Y5X9 4/20 0.50
TSHR P16473 1/20 0.50
TRPV1 Q8NER1 1/20 0.49
MGLL Q99685 1/20 0.49
HDAC1 Q13547 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
MLYCD O95822 1/20 0.47
ALDH1A1 P00352 1/20 0.46
HDAC3 O15379 2/20 0.45
HDAC2 Q92769 2/20 0.45
NCOR2 Q9Y618 1/20 0.43
LIMK1 P53667 1/20 0.43
LIMK2 P53671 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4949859 0.94 LPL (0.54) EGFRERBB2HPGDGAACA1
SCHEMBL12538103 0.90 MLYCD (0.58) EGFRERBB2HPGDGAACA1
SCHEMBL6674114 0.88 EGFR (0.70) EGFRERBB2HPGDGAATSHR
SCHEMBL133138 0.82 HPGD (0.58) HPGDMLYCDALDH1A1
SCHEMBL9645501 0.82 EGFR (0.63) EGFRERBB2HPGDGAATSHR
SCHEMBL6355135 0.81 HPGD (0.58) EGFRERBB2HPGDGAALPL
SCHEMBL10455765 0.81 EGFR (0.62) EGFRERBB2HPGDGAATSHR
SCHEMBL5968307 0.81 EGFR (0.62) EGFRERBB2HPGDGAATSHR
SCHEMBL5968306 0.81 EGFR (0.62) EGFRERBB2HPGDGAATSHR
SCHEMBL10725111 0.80 EGFR (0.61) EGFRERBB2HPGDGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919382-B2 Preparation and uses of conjugated solid supports for boronic acids THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2005-07-19 US disclosed
US-20030044840-A1 Preparation and uses of conjugated solid supports for boronic acids GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE (CA) 2003-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030044840-A1 Preparation and uses of conjugated solid supports for boronic acids SLC43A1, SBDS, SLC7A5 EGFR 703/4885ERBB2 367/4885HPGD 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.